NCT03027063View on ClinicalTrials.gov

Impact of Exercise on Mitigating the Cardio-toxic Effects of Adriamycin Among Women Newly Diagnosed With Breast Cancer.

NACompletedINTERVENTIONAL
Enrollment

21

Participants

Timeline

Start Date

January 31, 2017

Primary Completion Date

October 31, 2019

Study Completion Date

October 31, 2019

Conditions
Breast Cancer FemaleAdriamycin Toxicity
Interventions
BEHAVIORAL

10,000 steps

Participants will be asked to achieve 10,000 steps daily and to participate in 30 minutes of continuous exercise of their choosing. They will also receive text messages during the week and weekly motivational call

BEHAVIORAL

Usual Care

Participants will receive the ACC/AHA exercise guidelines

Trial Locations (1)

21218

Johns Hopkins Hospital, Baltimore

All Listed Sponsors
lead

Johns Hopkins University

OTHER

NCT03027063 - Impact of Exercise on Mitigating the Cardio-toxic Effects of Adriamycin Among Women Newly Diagnosed With Breast Cancer. | Biotech Hunter | Biotech Hunter